Results 141 to 150 of about 191,796 (284)

Clopidogrel Bisulfate [PDF]

, 2010
Maria L A D, Lestari, , Suciati, Gunawan, Indrayanto, Harry G, Brittain   +3 more
openaire   +2 more sources

Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose Alone [PDF]

, 2013
Jean G. Diodati, Jorge F. Saucedo, J. French, Anthony Fung, Tracy Cardillo, Carsten Henneges, Mark B. Effron, Harold Fisher, Dominick J. Angiolillo   +8 more
openalex   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

The effect of concurrent clopidogrel and omeprazole administration on clopidogrel metabolism and platelet function in healthy cats

Journal of Veterinary Internal Medicine
Background Some studies in humans show that the concurrent use of clopidogrel and omeprazole decreases plasma clopidogrel active metabolite (CAM) concentrations and clopidogrel antiplatelet effects. Whether this drug interaction occurs in cats is unknown.
Christina Plante, Pamela M. Lee, Jillian M. Haines, O. Lynne Nelson, Stephanie E. Martinez, Michael H. Court   +5 more
doaj   +1 more source

Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial [PDF]

, 2018
Kyungil Park, Young‐Rak Cho, Jong Sung Park, Tae‐Ho Park, Moo‐Hyun Kim, Young‐Dae Kim   +5 more
openalex   +1 more source

Simultaneous Intracranial and Spinal Hemorrhage Following Tenecteplase Thrombolysis for ST‐Elevation Myocardial Infarction: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Central nervous system (CNS) hemorrhage is a serious complication of intravenous thrombolysis. Tenecteplase, a fibrin‐specific thrombolytic agent, has a lower risk of hemorrhage than other agents. We report the first documented case of simultaneous intracranial and spinal hemorrhage following intravenous administration of tenecteplase.
Thamalee Palliyaguru, Pramith Ruwanpathirana, Praveen Weeratunga, Mythily Aravinthan, Thashi Chang   +4 more
wiley   +1 more source

Clopidogrel discontinuation and platelet reactivity following coronary stenting. [PDF]

, 2010
Aims: Antiplatelet therapy with aspirin and clopidogrel are recommended for 1 year after drug-eluting stent (DES) implantation or myocardial infarction. However, the discontinuation of antiplatelet therapy has become an important issue as recent studies ...
Dicker, Patrick, Foley, David, Kenny, Dermot, Mangiacapra, Fabio, Mylotte, Darren, Peace, Aaron, Tedesco, Tony   +6 more
core   +1 more source

Cost Effectiveness Analysis Of Ticagrelor Versus Generic Clopidogrel In The Treatment Of Patients With Acute Coronary Syndrome In Spain [PDF]

, 2014
Margarita Capel, José López‐Sendón, Manuel Heras, Francisco Jesús Represas Carrera, Max Brosa   +4 more
openalex   +1 more source

Selective Oxidation of Clopidogrel by Peroxymonosulfate (PMS) and Sodium Halide (NaX) System: An NMR Study [PDF]

, 2021
Everaldo F. Krake, Wolfgang Baumann
openalex   +1 more source

Low‐Dose Aspirin Induced Gastric Ulcer in a Patient With TIA: A Clinical Caution for Aspirin Therapy Without Gastroprotection

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Balancing the cerebrovascular benefits of low‐dose aspirin (LDA) with its significant gastrointestinal (GI) bleeding risk is a critical challenge in secondary stroke prevention. We describe a cautionary case of a 60‐year‐old male who, 6 months after starting LDA for a transient ischemic attack (TIA), presented with a life‐threatening upper GI ...
Kainat Husain, Muhammad Ibrahim, Fazeela Bibi, Khalil El Abdi, Bilal Aslam, Abdullah Saud, Vohra Maham Hassan, Aminullah Betanai, Muhammad Muneeb, Said Hamid Sadat   +9 more
wiley   +1 more source